Post by Amgen
1,762,474 followers
Amgen is investing an additional $300 million in its U.S. manufacturing network to further advance U.S.-based production capacity, enhance next-generation technologies and support a reliable supply of medicines for patients. This brings Amgen’s total announced U.S. manufacturing investments to nearly $2 billion over the past year. By growing our operations in Puerto Rico, we are ensuring patients have access to the medicines they need, investing in the long-term strength of our domestic supply chain and supporting American jobs. 🔗 See how Amgen is strengthening the future of American biomanufacturing: https://amgen.ly/4eJATPd
Video Content